LabCorp's Covance forms unit to focus on biologic drug development
March 13, 2018 at 12:33 PM EDT
The creation of the immunology and immunotoxicology unit by Covance Drug Development comes as LabCorp has focused on expanding its operations beyond laboratory diagnostics in order to become a global life sciences company.
